Results 71 to 80 of about 378 (110)

Identifying And Targeting Mechanisms Of Immune Cell Activation In Imcd-Tafro

open access: yes, 2021
Idiopathic multicentric Castleman disease (iMCD) is a rare, deadly hematologic illness of unknown etiology involving disease flares of systemic inflammation and multiple organ system dysfunction.
Pai, Ruth-Anne Langan
core  

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

open access: yes, 2018
Castleman disease (CD) describes a heterogeneous group of hematologic disorders that share characteristic lymph node histopathology. Patients of all ages present with either a solitary enlarged lymph node (unicentric CD) or multicentric lymphadenopathy ...
David C. Fajgenbaum
core   +1 more source

Highlighting Diagnostic Challenges and the Essential Role of Early Treatment in TAFRO Syndrome [PDF]

open access: yes
TAFRO 症候群は,血小板減少,全身浮腫,発熱,骨髄線維化,臓器腫大を特徴とする疾患である.まれな疾患であるため統計学的な研究がほとんど行われておらず,確立された治療ガイドラインや治療方針のコンセンサスを得られていない.本症例は74歳男性.発熱と顔面の腫脹を主訴に当院を受診した.本症例は体液貯留,血小板減少,原因不明の発熱と骨髄線維化と軽度の臓器腫大があったため診断基準の大項目3つ,小項目2つを満たしTAFRO 症候群と診断した ...
岡田, 莉子   +3 more
core  

キャッスルマン病 [PDF]

open access: yes
departmental bulletin ...
井出 眞
core  

Retrospective cohort evaluation of renal involvement in non-HIV castleman disease patients from a single academic center in Beijing, China. [PDF]

open access: yesAnn Hematol
Ling H   +13 more
europepmc   +1 more source

Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease. [PDF]

open access: yesJ Clin Pathol
Nishikori A   +15 more
europepmc   +1 more source

The morphological spectrum of Castleman disease and related disorders: a report from the Lymphoma Workshop of the 22nd Meeting of the European Association of Hematopathology. [PDF]

open access: yesVirchows Arch
Gasljevic G   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy